By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



540 – 1385 West 8th Avenue

Vancouver  British Columbia  V6H 3V9  Canada
Phone: 604-678-1388 Fax: 604-737-7077



Start Up

Company News
Eli Lilly (LLY) Adds $375 Million To Zymeworks Partnership 10/23/2014 6:56:08 AM
CMC Biologics And Zymeworks Enter Into Agreement For Process Development And Clinical Manufacture Of Bi-Specific Antibody Product Candidate 9/3/2014 11:47:03 AM
Zymeworks Announces Strategic Collaboration With Eli Lilly and Company (LLY) Subsidiary ImClone Systems (LLY) To Develop Bi-specific Antibodies Using Zymeworks' Azymetric™ Platform 1/9/2014 8:13:24 AM
Zymeworks Wraps Up $15 Million Funding Round 1/9/2014 7:00:35 AM
Zymeworks Announces the Addition of Dr. Leonard Presta to its Scientific Advisory Board 8/15/2013 7:00:19 AM
Zymeworks to Receive an Undisclosed Amount From Merck & Co., Inc. (MRK), Part of a $187 Million Alliance 4/16/2013 7:14:07 AM
Zymeworks Raises $11 Million, Hits Antibody Drug Milestone for Merck & Co., Inc. (MRK) 9/6/2012 7:57:01 AM
Zymeworks Announces the Formation of its Therapeutics Advisory Team, and Appointment of VP, Preclinical R&D to Advance its Strategic Therapeutics Initiative 1/5/2012 6:24:20 AM
Zymeworks Completes $8.1 Million Round of Financing to Advance Platform Technology and Therapeutics Pipeline Programs 9/22/2011 6:39:36 AM
Zymeworks Snags $187 Million Deal With Merck & Co., Inc. (MRK) to Discover Multi-Pronged Antibodies 8/29/2011 7:15:40 AM